Symbol | Exchange | Currency |
|---|
Investing.com – Mexico stocks were higher after the close on Tuesday, as gains in the Consumer Staples, Healthcare and Telecoms Services sectors led shares higher. At the close in...
Investing.com – Mexico stocks were higher after the close on Monday, as gains in the Healthcare, Consumer Staples and Materials sectors led shares higher. At the close in Mexico,...
Investing.com – Mexico stocks were higher after the close on Thursday, as gains in the Healthcare, Financial Services and Telecoms Services sectors led shares higher. At the close...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Buy | Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,402.22 | 2,432.06 | 2,400.30 | -32.65 | -1.34% | 2.31M | NASDAQ | |||
| 329.66 | 336.15 | 329.00 | -6.85 | -2.04% | 23.04M | NASDAQ | |||
| 22.58 | 22.79 | 22.52 | -0.23 | -1.01% | 102.34K | NYSE | |||
| 19.57 | 19.57 | 19.41 | -0.06 | -0.31% | 1.40M | NYSE | |||
| 5.85 | 6.03 | 5.69 | -0.30 | -4.88% | 205.81K | NYSE | |||
| 13.28 | 14.00 | 13.26 | -0.28 | -2.06% | 5.25M | NYSE | |||
| 2.91 | 2.95 | 2.88 | -0.07 | -2.35% | 449.81K | NYSE | |||
| 17.01 | 17.27 | 16.98 | -0.24 | -1.39% | 1.01M | NYSE | |||
| 2,511.35 | 2,527.78 | 2,492.06 | -16.07 | -0.64% | 2.67M | NASDAQ | |||
| 60.85 | 60.97 | 59.53 | +0.14 | +0.23% | 13.27M | NYSE | |||
| 212.30 | 213.84 | 210.59 | +0.70 | +0.33% | 13.72M | NYSE | |||
| 92.25 | 96.54 | 91.86 | -5.86 | -5.97% | 1.86M | NYSE | |||
| 8.74 | 9.05 | 8.63 | -0.46 | -5.00% | 16.89M | NYSE | |||
| 59.26 | 64.96 | 56.85 | -1.47 | -2.42% | 243.65M | NYSE | |||
| 45.23 | 45.75 | 44.43 | +0.99 | +2.24% | 34.85M | NYSE |
Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.
